Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

34.26
Delayed Data
As of Sep 23
 +0.11 / +0.32%
Today’s Change
28.25
Today|||52-Week Range
37.39
+6.13%
Year-to-Date
The 5 Highest Dividend Payout Ratios on the Dow
Sep 23 / MotleyFool.com - Paid Partner Content
Sanofi Sues Merck Over Patent Infringement
Sep 20 / GuruFocus News - Paid Partner Content
Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Con...
Sep 23 / Zacks.com - Paid Partner Content
Incoming GSK chief faces challenge to maintain momentum
Sep 20 / FT.com - Paid Partner Content
John Paulson Trims Synergy
Sep 23 / GuruFocus News - Paid Partner Content
Big pharma targets drug-resistant superbugs
Sep 20 / FT.com - Paid Partner Content
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Sep 23 / Zacks.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
Will the Monsanto-Bayer Deal Go Through?
Sep 20 / GuruFocus News - Paid Partner Content
Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close34.15
Today’s open34.16
Day’s range34.01 - 34.37
Volume12,937,101
Average volume (3 months)21,490,570
Market cap$207.8B
Dividend yield3.50%
Data as of 4:00pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+11.80%
Earnings growth (next 5 years)+6.90%
Revenue growth (last year)-1.52%
P/E ratio30.3
Price/Sales4.13
Price/Book3.27

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.55-0.67%
MRKMerck-0.06-0.10%
GSKGlaxoSmithKline-0.16-0.37%
ABBVAbbVie-0.10-0.15%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.62
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts

Search for Jobs